BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16988944)

  • 21. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
    Bhatt KV; Hu R; Spofford LS; Aplin AE
    Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML.
    Brakensiek K; Länger F; Kreipe H; Lehmann U
    Leuk Res; 2005 Nov; 29(11):1357-60. PubMed ID: 15936816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterisation of cell cycle arrest and terminal differentiation in a maximally proliferative human epithelial tissue: Lessons from the human hair follicle matrix.
    Purba TS; Brunken L; Peake M; Shahmalak A; Chaves A; Poblet E; Ceballos L; Gandarillas A; Paus R
    Eur J Cell Biol; 2017 Sep; 96(6):632-641. PubMed ID: 28413121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.
    Lu Z; Hunter T
    Cell Cycle; 2010 Jun; 9(12):2342-52. PubMed ID: 20519948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of p27
    Kim GJ; Kim DH; Min KW; Kim YH; Oh YH
    Pathol Res Pract; 2018 Apr; 214(4):565-571. PubMed ID: 29482985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
    Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
    Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells.
    Shin JY; Kim HS; Park J; Park JB; Lee JY
    Cancer Res; 2000 Jan; 60(2):262-5. PubMed ID: 10667572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
    J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mdig, a lung cancer-associated gene, regulates cell cycle progression through p27(KIP1).
    Ma D; Guo D; Li W; Zhao H
    Tumour Biol; 2015 Sep; 36(9):6909-17. PubMed ID: 25851349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and mutational analysis of Cip/Kip family in early glottic cancer.
    Kim DK; Lee JH; Lee OJ; Park CH
    J Laryngol Otol; 2015 Feb; 129(2):168-73. PubMed ID: 25695279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells.
    Bilodeau S; Roussel-Gervais A; Drouin J
    Mol Cell Biol; 2009 Apr; 29(7):1895-908. PubMed ID: 19139274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
    Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
    Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation of p16(INK4A) and p57(KIP2) are involved in the development and progression of gastric MALT lymphomas.
    Min KO; Seo EJ; Kwon HJ; Lee EJ; Kim WI; Kang CS; Kim KM
    Mod Pathol; 2006 Jan; 19(1):141-8. PubMed ID: 16357845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation.
    Figliola R; Busanello A; Vaccarello G; Maione R
    J Mol Biol; 2008 Jul; 380(2):265-77. PubMed ID: 18513743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70.
    Zou P; Yoshihara H; Hosokawa K; Tai I; Shinmyozu K; Tsukahara F; Maru Y; Nakayama K; Nakayama KI; Suda T
    Cell Stem Cell; 2011 Sep; 9(3):247-61. PubMed ID: 21885020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway.
    Vlachos P; Nyman U; Hajji N; Joseph B
    Cell Death Differ; 2007 Aug; 14(8):1497-507. PubMed ID: 17464323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of p27
    Russo GL; Stampone E; Cervellera C; Borriello A
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32933137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101.
    Sinuani I; Weissgarten J; Beberashvili I; Rapoport MJ; Sandbank J; Feldman L; Albeck M; Averbukh Z; Sredni B
    Nephrol Dial Transplant; 2009 Aug; 24(8):2328-38. PubMed ID: 19321762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
    Hartmann W; Waha A; Koch A; Goodyer CG; Albrecht S; von Schweinitz D; Pietsch T
    Am J Pathol; 2000 Oct; 157(4):1393-403. PubMed ID: 11021841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.